Aphios Corporation is developing enabling technology platforms for improving drug discovery, manufacturing, delivery and pathogenic safety, and enhanced therapeutics for health maintenance, disease prevention and the treatment of certain infectious diseases, cancers and CNS disorders.
Aphios Awarded US Patent Covering Nanoencapsulation of Therapeutic Proteins
Aphios, SAIC-Frederick Sign Subcontract to Develop Nanosomal Formulations for Cancer Treatment
Aphios Secures NIA SBIR Grant to Develop Nanodrug for Alzheimer’s Disease
Aphios Receives U.S. Patent to Formulate Polymer Nanospheres
In this interview, we speak with Stanford's Gu Group about their newly developed metal nanocluster-based material that's advancing nanoscale 3D printing.
Professor Andre Nel
In this interview, AZoNano speaks with Professor Andre Nel about his involvement in innovative research describing the development of a 'glass bubble' nanocarrier that could help drug formulations access pancreatic cancer cells.
Jingang Li, Ph.D.
In this interview, AZoNano speaks with Jingang Li from the University of California, Berkley, who offers an introduction to the Nobel Prize-winning technology, Optical Tweezers.
The MiniCapt® Pro is a remote microbial air sampler that is ideal for the pharmaceutical manufacturing industry.
This product profile outlines the NanoRacer High-Speed AFM from Bruker JPK.
NMR spectroscopy is a characterization technique that is extensively used by chemical researchers.